Related Experiment Videos
Genetics of left ventricular hypertrophy and its regression
1Medicina 1, Hospital de Santa Maria, Faculdade de Medicina de Lisboa, Portugal.
Summary
Genetic factors influence left ventricular hypertrophy (LVH) in hypertension. Identifying specific genetic profiles may predict how well LVH regresses with different blood pressure medications.
Area of Science:
- Cardiology
- Genetics
- Pharmacology
Background:
- Left ventricular hypertrophy (LVH) is a significant complication of hypertension.
- LVH development involves complex interactions between genetic, hemodynamic, neurohumoral, and environmental factors.
Purpose of the Study:
- To review the primary genetic alterations associated with cardiac hypertrophy.
- To identify genetic polymorphisms linked to LVH development and regression.
- To explore the potential of genetic profiling in predicting therapeutic regression of LVH.
Main Methods:
- Literature review of genetic studies on cardiac hypertrophy.
- Analysis of genetic polymorphisms associated with left ventricular hypertrophy.
- Examination of studies on the regression of LVH in response to antihypertensive drugs.
Main Results:
- Several genetic alterations contribute to cardiac hypertrophy.
- Specific genetic polymorphisms are consistently associated with LVH development.
- These polymorphisms may also influence the regression of LVH induced by therapy.
Conclusions:
- Genetic factors play a crucial role in the development and regression of left ventricular hypertrophy.
- Future identification of genetic profiles could personalize antihypertensive treatment strategies.
- Predicting LVH regression based on genetics may optimize therapeutic outcomes.